Researchers analyzed blood and virus samples, clinical data and self-reported symptoms from 309 COVID-19 patients to identify biological associations that occur in people with post acute sequelae of COVID-19, or long COVID-19.
They identified four risk factors for long COVID-19 that can be assessed at the time of diagnosis:
- Pre-existing Type 2 diabetes
- SARS-CoV-2 RNA levels in the blood
- Epstein-Barr virus DNA levels in the blood
- The presence of specific autoantibodies
“Identifying these PASC factors is a major step forward for not only understanding long COVID and potentially treating it, but also which patients are at highest risk for the development of chronic conditions,” said study author Jim Heath, PhD, president of the Institute for Systems Biology, a Seattle-based nonprofit biomedical research organization affiliated with Renton, Wash.-based Providence.
Researchers also found that both mild and severe COVID-19 cases were associated with long COVID-19.
They said more research is needed to establish a causal link between risk factors and long COVID-19. The study also only looked at COVID-19 symptoms up to three months after diagnosis, which is another limitation.
Learn more here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.